LFSC vs. IBB
Compare and contrast key facts about F/m Emerald Life Sciences Innovation ETF (LFSC) and iShares Nasdaq Biotechnology ETF (IBB).
LFSC and IBB are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. LFSC is an actively managed fund by F/m Investments. It was launched on Oct 30, 2024. IBB is a passively managed fund by iShares that tracks the performance of the NASDAQ Biotechnology Index. It was launched on Feb 5, 2001.
Performance
LFSC vs. IBB - Performance Comparison
Loading graphics...
LFSC vs. IBB - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | |
|---|---|---|---|
LFSC F/m Emerald Life Sciences Innovation ETF | -4.62% | 56.54% | -6.02% |
IBB iShares Nasdaq Biotechnology ETF | 0.88% | 27.98% | -5.72% |
Returns By Period
In the year-to-date period, LFSC achieves a -4.62% return, which is significantly lower than IBB's 0.88% return.
LFSC
- 1D
- -0.19%
- 1M
- -3.88%
- YTD
- -4.62%
- 6M
- 18.37%
- 1Y
- 59.47%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
IBB
- 1D
- 0.76%
- 1M
- -2.11%
- YTD
- 0.88%
- 6M
- 14.77%
- 1Y
- 37.04%
- 3Y*
- 9.92%
- 5Y*
- 2.62%
- 10Y*
- 6.92%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
LFSC vs. IBB - Expense Ratio Comparison
LFSC has a 0.54% expense ratio, which is higher than IBB's 0.47% expense ratio.
Return for Risk
LFSC vs. IBB — Risk / Return Rank
LFSC
IBB
LFSC vs. IBB - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for F/m Emerald Life Sciences Innovation ETF (LFSC) and iShares Nasdaq Biotechnology ETF (IBB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| LFSC | IBB | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 2.06 | 1.56 | +0.50 |
Sortino ratioReturn per unit of downside risk | 2.79 | 2.16 | +0.64 |
Omega ratioGain probability vs. loss probability | 1.35 | 1.28 | +0.07 |
Calmar ratioReturn relative to maximum drawdown | 3.42 | 2.86 | +0.56 |
Martin ratioReturn relative to average drawdown | 9.51 | 10.20 | -0.69 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| LFSC | IBB | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 2.06 | 1.56 | +0.50 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | — | 0.12 | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.30 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.94 | 0.26 | +0.68 |
Correlation
The correlation between LFSC and IBB is 0.75, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Dividends
LFSC vs. IBB - Dividend Comparison
LFSC has not paid dividends to shareholders, while IBB's dividend yield for the trailing twelve months is around 0.23%.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
LFSC F/m Emerald Life Sciences Innovation ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
IBB iShares Nasdaq Biotechnology ETF | 0.23% | 0.23% | 0.29% | 0.26% | 0.31% | 0.21% | 0.21% | 0.33% | 0.20% | 0.30% | 0.19% | 0.03% |
Drawdowns
LFSC vs. IBB - Drawdown Comparison
The maximum LFSC drawdown since its inception was -29.74%, smaller than the maximum IBB drawdown of -62.85%. Use the drawdown chart below to compare losses from any high point for LFSC and IBB.
Loading graphics...
Drawdown Indicators
| LFSC | IBB | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -29.74% | -62.85% | +33.11% |
Max Drawdown (1Y)Largest decline over 1 year | -16.25% | -11.65% | -4.60% |
Max Drawdown (5Y)Largest decline over 5 years | — | -39.82% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -39.82% | — |
Current DrawdownCurrent decline from peak | -11.25% | -4.16% | -7.09% |
Average DrawdownAverage peak-to-trough decline | -8.26% | -21.30% | +13.04% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.84% | 3.27% | +2.57% |
Volatility
LFSC vs. IBB - Volatility Comparison
F/m Emerald Life Sciences Innovation ETF (LFSC) has a higher volatility of 10.08% compared to iShares Nasdaq Biotechnology ETF (IBB) at 8.38%. This indicates that LFSC's price experiences larger fluctuations and is considered to be riskier than IBB based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| LFSC | IBB | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 10.08% | 8.38% | +1.70% |
Volatility (6M)Calculated over the trailing 6-month period | 19.95% | 14.50% | +5.45% |
Volatility (1Y)Calculated over the trailing 1-year period | 29.12% | 24.01% | +5.11% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 29.27% | 21.87% | +7.40% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 29.27% | 23.37% | +5.90% |